Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

× No keyword cloud information.

76 in total

1. The quinolones.

Authors: R J Fass
Journal: Ann Intern Med Date: 1985-03 Impact factor: 25.391

2. Investigations into the mechanism of action of the antibacterial agent norfloxacin.

Authors: G C Crumplin; M Kenwright; T Hirst
Journal: J Antimicrob Chemother Date: 1984-05 Impact factor: 5.790

3. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.

Authors: A L Barry; R N Jones
Journal: Antimicrob Agents Chemother Date: 1984-06 Impact factor: 5.191

4. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.

Authors: J M Bailey; C Heppleston; S J Richmond
Journal: Antimicrob Agents Chemother Date: 1984-07 Impact factor: 5.191

5. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors: J D Gay; D R DeYoung; G D Roberts
Journal: Antimicrob Agents Chemother Date: 1984-07 Impact factor: 5.191

6. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors: M W Hane; T H Wood
Journal: J Bacteriol Date: 1969-07 Impact factor: 3.490

7. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors: G M Eliopoulos; A Gardella; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1984-03 Impact factor: 5.191

8. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.

Authors: R Wise; J M Andrews; G Danks
Journal: J Antimicrob Chemother Date: 1984-03 Impact factor: 5.790

9. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors: C C Sanders; W E Sanders; R V Goering; V Werner
Journal: Antimicrob Agents Chemother Date: 1984-12 Impact factor: 5.191

10. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors: R Wise; J M Andrews; L J Edwards
Journal: Antimicrob Agents Chemother Date: 1983-04 Impact factor: 5.191

207 in total

Review 1. Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors: J S Wolfson
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-12 Impact factor: 3.267

2. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.

Authors: Myo-Kyoung Kim; Charles Nightingale; David Nicolau
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

3. The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase.

Authors: S T Dobbs; P M Cullis; A Maxwell
Journal: Nucleic Acids Res Date: 1992-07-25 Impact factor: 16.971

4. Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing.

Authors: J J Goswitz; K E Willard; C E Fasching; L R Peterson
Journal: Antimicrob Agents Chemother Date: 1992-05 Impact factor: 5.191

8. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Authors: U B Schaad; J Wedgwood-Krucko; K Guenin; U Buehlmann; R Kraemer
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-10 Impact factor: 3.267

Review 9. Impact of the fluoroquinolones on gastrointestinal flora.

Authors: V Korten; B E Murray
Journal: Drugs Date: 1993 Impact factor: 9.546

Review 10. Fluoroquinolones: interaction profile during enteral absorption.

Authors: K M Deppermann; H Lode
Journal: Drugs Date: 1993 Impact factor: 9.546

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.